Autopsy report · NCT04711850

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

“This is an internal decision based on prioritisations and no safety issues have been raised during the trial.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 2 months before it stopped.
• 18 participants enrolled.
• Results were posted on the registry 2 years 1 month after it ended.

Vital statistics

Status

Terminated

Sponsor

Hansa Biopharma AB

Sponsor type

Industry

Conditions

Kidney Transplant Rejection

Interventions

Imlifidase

Participants

18

Sites

7

Countries

Austria, France, Germany

Trials that died the same way

• MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
  “Business Decision; No Safety Or Efficacy Concerns.” (68% match in meaning)
• A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
  “The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.” (65% match in meaning)
• A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
  “Sponsor decision to cancel trial, not related to safety concern.” (65% match in meaning)
• Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
  “Business Decision; No Safety Or Efficacy Concerns. (See below)” (64% match in meaning)
• A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
  “Not due to safety concerns, but changes in strategy which this trial no longer fulfills.” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.